$CCRN

Clark Kevin Cronin sold (to issuer) $52K of CCRN (indirect holdings)

Clark Kevin Cronin (Chief Executive Officer) sold (to issuer) 3,961 indirectly-held shares of CROSS COUNTRY HEALTHCARE INC (CCRN) at $13.25 on 2026-07-21.

Original reporting
SEC EDGAR · Clark Kevin Cronin
Published Jul 21, 2026, 8:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 21, 2026, 8:16 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CCRN
Neutral
high confidence
Mentioned
$CCRN
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CCRNNeutralLow
01

Why it matters

The disclosure provides a datapoint on insider activity but no new operational or financial information.

02

Market read

Traders may note insider selling activity, but the filing lacks fundamental catalysts and is unlikely to drive sustained repricing.

03

What to watch

Sale is to the issuer (often buyback participation) and the filing states no 10b5-1 plan, which can reduce interpretability versus standard planned sales.

Relevance 3/10Novelty 2/10Timing: Filed 2026-07-21, after-hours SEC EDGAR disclosure.

Background

SEC Form 4 insider transaction for Cross Country Healthcare, Inc. (CCRN) by CEO Clark Kevin Cronin.

Company-level read

Ticker impact

$CCRNNeutralHigh confidence
Context

Form 4 shows CEO Clark Kevin Cronin sold 3,961 shares to the issuer for $52,483.25 at $13.25 on 2026-07-21.

Expected impact

Minimal near-term impact; any reaction is likely sentiment-driven and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction, but it does not disclose new company performance, guidance, or material corporate events.

Market effects

None; transaction is company-specific and does not indicate sector-wide change.

None.

None.

Counterpoint

If the sale is interpreted as liquidity-driven rather than informational, it may be even less meaningful than typical insider selling.

Key entities

  • Cross Country Healthcare, Inc.

    Company whose CEO filed the Form 4 insider transaction (CCRN).

  • Clark Kevin Cronin

    CEO and director who sold shares to the issuer via Form 4.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LWAYLow

Divisadero Street Capital Management, LP (Zolezzi William) purchased $6.1M of LWAY (indirect holdings)

Divisadero Street Capital Management, LP purchased 246,568 indirectly-held shares of Lifeway Foods, Inc. (LWAY) at an average of $24.85 ($24.69–$24.87, $6.13M total) across 3 trades over 2026-08-13 to 2026-08-17. Filed jointly with Divisadero Street Partners GP, LLC (10% owner), Divisadero Street Capital, LLC (10% owner), Divisadero Street Partners, L.P. (10% owner) and Zolezzi William (10% owner).